Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study
1 other identifier
observational
19
1 country
1
Brief Summary
Observational analytic study with prospective cohort design that aim to describe the presence of typical features of migraine in a cohort of nummular headache patients. The aim of the study is to analyze family history, epidemiology, clinical description, presence of prodromes, postdromes and response to treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2020
CompletedFirst Posted
Study publicly available on registry
March 9, 2020
CompletedStudy Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2023
CompletedSeptember 22, 2023
September 1, 2023
3 years
March 5, 2020
September 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Family history of migraine
To assess family history of migraine headache in nummular patients. We will build family tree up to 3 generations and we will ask patients to complete it by questioning their relatives.
Through study completion, an average of 1 month
Epidemiological pattern
To determine age of onset, age when they were diagnosed, temporal pattern and frequency of headache.
Through study completion, an average of 1 month
Clinical phenotype
To assess the clinical characteristics of nummular headache, analyzing the presence of typical features of migraine. Patients will complete a prospective headache diary for 15 days.
Through study completion, an average of 1 month
Presence of associated symptoms
To assess the presence of symptoms such as nausea, vomiting, dizziness during the headache episodes.
Through study completion, an average of 1 month
Presence of prodromes
To assess the presence of typical migraine prodromes before the headache episodes.
Through study completion, an average of 1 month
Presence of postdromes
To assess the presence of typical migraine postdromes after the headache episode.
Through study completion, an average of 1 month
Presence of sensory disturbances
To evaluate the presence of sensory changes such as hypoesthesia, hyperalgesia or allodinia upon examination.
Through study completion, an average of 1 month
Response to acute treatment
To describe response to prior acute medications.
Through study completion, an average of 1 month
Response to prophylactic treatment
To assess response to prior prophylactic treatments.
Through study completion, an average of 1 month
Interventions
In the first visit they will be examined by a neurologist with experience in headache disorders and NH diagnosis will be reviewed. Patients will be invited to participate into the study and they will provide and sign informed consent form. They will be instructed and trained to complete the prospective headache diary during 14 days. A follow up visit will be done within 15 to 30 days to review the data and analyze possible sources of bias.
Eligibility Criteria
Patients with definite diagnosis of nummular headache that visit the headache outpatient clinic of Valladolid University Hospital.
You may qualify if:
- Diagnosis of Nummular Headache (NH) according to the International Classification of Headache Disorders, 3rd version (ICHD-3).
- More than 3 months of NH evolution.
- No better accounted for by another ICHD-3 diagnosis.
- Older than 18 years.
- Capable of prospectively register headache characteristics in a diary.
- Ability to provide informed consent form.
You may not qualify if:
- Other primary or secondary headache, except for infrequent tension-type headache or medication overuse headache.
- Major psychiatric disorders.
- Alcoholism or drug use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Clínico Universitario Valladolid
Valladolid, 47003, Spain
Related Publications (5)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available.
PMID: 29368949BACKGROUNDPareja JA, Caminero AB, Serra J, Barriga FJ, Baron M, Dobato JL, Vela L, Sanchez del Rio M. Numular headache: a coin-shaped cephalgia. Neurology. 2002 Jun 11;58(11):1678-9. doi: 10.1212/wnl.58.11.1678.
PMID: 12058099BACKGROUNDTrigo J, Garcia-Azorin D, Martinez Pias E, Sierra A, Chavarria A, Guerrero AL. Clinical characteristics of nummular headache and differentiation between spontaneous and posttraumatic variant: an observational study. J Headache Pain. 2019 Apr 8;20(1):34. doi: 10.1186/s10194-019-0981-4.
PMID: 30961529BACKGROUNDGarcia-Azorin D, Trigo-Lopez J, Sierra A, Blanco-Garcia L, Martinez-Pias E, Martinez B, Talavera B, Guerrero AL. Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study. Cephalalgia. 2019 Dec;39(14):1818-1826. doi: 10.1177/0333102419863023. Epub 2019 Jul 4.
PMID: 31272194BACKGROUNDCuadrado ML, Lopez-Ruiz P, Guerrero AL. Nummular headache: an update and future prospects. Expert Rev Neurother. 2018 Jan;18(1):9-19. doi: 10.1080/14737175.2018.1401925. Epub 2017 Nov 9.
PMID: 29103335BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 5, 2020
First Posted
March 9, 2020
Study Start
April 1, 2020
Primary Completion
March 25, 2023
Study Completion
April 25, 2023
Last Updated
September 22, 2023
Record last verified: 2023-09